Complizen Learn

Reduce medical device clinical trial costs by 40-60% through strategic FDA engagement and smart study design. The #1 cost saver: Pre-Sub meeting ($50K investment) clarifies whether FDA will accept single-arm vs RCT, smaller patient counts, or shorter followup—potentially saving $2M-$5M before you commit to trial design. Other high-impact strategies: use single-arm design when FDA accepts objective endpoints (cuts costs 40-50% vs RCT), optimize site count to 5-8 sites (vs 15-2

AI can speed up 510(k) predicate research by 70-80%, find relevant FDA guidance in minutes instead of hours, and organize evidence trails automatically. But AI cannot make regulatory strategy decisions, replace required testing, or take accountability for submission content. Best results: Use AI for research-heavy tasks (finding predicates, FDA guidance, standards), pair with regulatory consultant for strategy and review. Cost comparison: AI tools $200-$2K/month vs. consultan

Medical device clinical trials vary widely in cost depending on device risk class, study design, patient count, duration, and endpoints . Typical total budgets range from ≈$1 M to $20 M+ for studies supporting regulatory submissions – with higher budgets common for large pivotal trials. Per-participant costs for device studies often range from about $14,000 to $50,000+ per enrolled patient depending on complexity and follow-up. Many companies overspend because they assume c

FDA inspects medical device manufacturers to verify compliance with 21 CFR Part 820 quality system requirements , using a structured approach often associated with the QSIT inspection method. Inspections can be routine surveillance or for-cause , such as follow-up to significant complaints, recalls, or other risk signals. Plan 8–24 weeks to get inspection-ready by closing CAPA gaps, organizing DHF and DMR records, confirming complaint handling, and running a mock audit. Du

Choose your sterilization method based on material compatibility first , then regulatory precedent, cost, and timeline . Ethylene oxide (EO) is the most widely used method across medical devices and works for many complex, low-temperature materials, but total turnaround often takes 1–3 weeks including aeration. Steam sterilization is the fastest and least expensive , but only suitable for heat- and moisture-stable devices. Gamma radiation is effective for some polymers but c

To bring a medical device to the U.S. market: (1) Classify your device (Class I, II, or III), (2) select your regulatory pathway (510(k), De Novo, or PMA), (3) complete required testing, (4) prepare and submit your FDA application, and (5) maintain post-clearance QMS compliance. Timeline ranges from 3-6 months for 510(k) to 1-3 years for PMA. This guide provides the complete roadmap from concept to U.S. market launch, with decision frameworks at each stage to help you avoid t

Medical device development costs vary by classification: Class I ($200K-$2M), Class II ($2M-$30M), and Class III ($5M-$119M+). Major expenses include clinical trials (40-60% of budget), regulatory activities (10-15%), manufacturing setup (15-25%), and commercialization (10-20%). Timeline spans 1-7 years depending on complexity and pathway. The #1 question every medtech entrepreneur asks: "How much funding do I actually need?" The answer depends on your device classification,

An FDA medical device recall is usually a voluntary action by a firm to remove or correct a product that violates FDA law, with FDA classifying the recall as Class I, II, or III by health risk. Device firms must also follow 21 CFR Part 806 (report certain corrections/removals within 10 working days). This guide covers everything Medtech companies need to prevent FDA recalls, respond to crises, and navigate the agency's enforcement. What Is an FDA Recall? An FDA medical-device

Choosing an FDA pathway hinges on risk, novelty, and predicates. Use 510(k) when a suitable predicate exists for the same intended use and technology (typically Class II). Choose De Novo for novel, low-to-moderate-risk devices without a predicate—this creates a new classification. Use PMA for Class III, high-risk or life-supporting devices requiring proof of safety and effectiveness. Article Outline Section Topic Key Focus Quick Decision Framework 30-second pathway selector I